Telemedicine Decreases No-Show Rates and Achieves Comparable Outcomes in Publicly Insured Patients With Type 2 Diabetes
Authors' conclusion
Publicly insured patients with T2D showed significantly reduced no-show rates and comparable glycemic control during telemedicine visits compared with in-person visits. Telemedicine visits may be associated with lower no-show rates due to a reduction of socioeconomic barriers. Future studies are warranted to further clarify potential associations of specific socioeconomic barriers to missed visits.
Study context
- Population
- Publicly insured patients with T2D at the Yale Medicine Diabetes Center
- Participants
- 819 participants
- Exposure
- Telemedicine vs in-person visits
- Outcome
- No-show rates
Methodological detailssame patients compared between in-person and telehealth periods
- Same patients compared between in-person and telehealth periods
Main finding
As reported in the abstract
Telemedicine
0.34
mean · ± 0.69
In-person
1.19
mean · ± 1.30
P < 0.001
Observational data: associations, not effects.
Further findings
Patients achieving ≥70% TIR on ambulatory glucose profile
P = 0.76
| Outcome | Telemedicine | In-person | P value |
|---|---|---|---|
| HbA1c | mean 7.93 ± 1.95 | mean 7.91 ± 1.90 | P = 0.65 |
Original publication
Telemedicine Decreases No-Show Rates and Achieves Comparable Outcomes in Publicly Insured Patients With Type 2 Diabetes. J Diabetes Sci Technol. Published 29 July 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →